G8 Gleneagles Africa Statement

Sectors : Health systems, medicines and regulation, Polio, Malaria, TB, Health and technology, HIV/AIDS
Organisation : G8
Date made: 
2005
You are viewing a filtered list of commitments, click here to view all commitments in this text

Commitments in: Health - Health systems, medicines and regulation

“15. Life expectancy is increasing in every continent except Africa, where it has been falling for the last 20 years. We will continue to support African strategies to improve health, education and food security.

16. To unlock the vast human potential of Africa, we will work with Africa to create an environment where its most capable citizens, including teachers and healthcare workers, see a long-term future on the continent. We will work with committed national governments to assist in creating that environment…

18. We will work to achieve these aims by: …

…(c) Investing in improved health systems in partnership with African governments, by helping Africa train and retain doctors, nurses and community health workers. We will ensure our actions strengthen health systems at national and local level and across all sectors since this is vital for long-term improvements in overall health, and we will encourage donors to help build health capacity.

Scope: 
Africa

Commitments in: Health - Polio

“18. We will work to achieve these aims by: …

… (f) Supporting the Polio Eradication Initiative for the post eradication period in 2006-8 through continuing or increasing our own contributions toward the $829 million target and mobilising the support of others. We are pleased that the funding gap for 2005 has been met.”

Scope: 
Africa

Commitments in: Health - Malaria

“18. We will work to achieve these aims by: …

… (g) Working with African countries to scale up action against malaria to reach 85% of the vulnerable populations with the key interventions that will save 600,000 children’s lives a year by 2015 and reduce the drag on African economies from this preventable and treatable disease. By contributing to the additional $1.5bn a year needed annually to help ensure access to anti-malaria insecticide-treated mosquito nets, adequate and sustainable supplies of Combination Therapies including Artemisin, presumptive treatment for pregnant women and babies, household residual spraying and the capacity in African health services to effectively use them, we can reduce the burden of malaria as a major killer of children in sub-Saharan Africa.”

Scope: 
Africa

Commitments in: Health - TB

“18. We will work to achieve these aims by: …

… (h) Helping to meet the needs identified by the Stop TB Partnership. We also support the call for a high-level conference of Health Ministers for TB in 2006.”

Scope: 
Africa

Commitments in: Health - HIV/AIDS

“18. We will work to achieve these aims by: …

… (d) With the aim of an AIDS-free generation in Africa, significantly reducing HIV infections and working with WHO, UNAIDS and other international bodies to develop and implement a package for HIV prevention, treatment and care, with the aim of as close as possible to universal access to treatment for all those who need it by 2010. Limited health systems capacity is a major constraint to achieving this and we will work with our partners in Africa to address this, including supporting the establishment of reliable and accountable supply chain management and reporting systems. We will also work with them to ensure that all children left orphaned or vulnerable by AIDS or other pandemics are given proper support. We will work to meet the financing needs for HIV/AIDS, including through the replenishment this year of the Global Fund to fight AIDS, TB and Malaria; and actively working with local stakeholders to implement the ‘3 Ones’ principles in all countries.

(e) Building on the valuable G8 Global HIV/AIDS vaccine enterprise, increasing direct investment and taking forward work on market incentives, as a complement to basic research, through such mechanisms as Public Private Partnerships and Advance Purchase Commitments to encourage the development of vaccines, microbicides and drugs for AIDS, malaria, tuberculosis and other neglected diseases. We note continuing work to explore establishing an International Centre for Genetic Engineering & Biotechnology centre in Africa to help research into vaccines for the diseases that are afflicting the continent.

Scope: 
Africa